Asean

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time

Read More

CGTN: China-Europe Ties: Shaping the Next 50 Years

CGTN: China-Europe Ties: Shaping the Next 50 Years BEIJING, Dec. 04, 2025 (GLOBE NEWSWIRE) — This year marks the 50th anniversary of the establishment of diplomatic relations between China and the European Union – a pivotal moment not only for reflecting on the past, but for exploring the pathway for

Read More

Meltwater Named a Leader in IDC MarketScape: Worldwide Influencer Marketing Platforms for SMB Companies 2025-2026

SAN FRANCISCO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and influencer intelligence, has been recognized as a Leader in the new IDC MarketScape: Worldwide Influencer Management for SMB Companies 2025–2026 Vendor Assessment (doc #US52967425, November 2025). The recognition follows Meltwater’s recent recognition as a

Read More